{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:46:04Z","timestamp":1777311964239,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Marmara University Scientific Research Project Coordination Unit","award":["ADT-2022-10661"],"award-info":[{"award-number":["ADT-2022-10661"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10875-024-01791-w","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T03:02:25Z","timestamp":1726455745000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Diverse Clinical and Immunological Profiles in Patients with IPEX Syndrome: a Multicenter Analysis from Turkey"],"prefix":"10.1007","volume":"45","author":[{"given":"Hayrunnisa","family":"Bekis Bozkurt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feyza","family":"Bayram Catak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezgi","family":"Yalcin Gungoren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betul","family":"Gemici Karaarslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalan","family":"Yakici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melek","family":"Yorgun Altunbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Cihangir","family":"Catak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Can","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razin","family":"Amirov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selcen","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Necmiye","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevgi","family":"Bilgic Eltan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurhan","family":"Kasap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Bal Cetinkaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazil","family":"Orhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Arga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem","family":"Cavkaytar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayca","family":"Kiykim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Karakoc-Aydiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safa","family":"Baris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"1791_CR1","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.3389\/fimmu.2018.02411","volume":"9","author":"E Gambineri","year":"2018","unstructured":"Gambineri E, CiulliniMannurita S, Hagin D, Vignoli M, Anover-Sombke S, DeBoer S, et al. Clinical, Immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, X-Linked (IPEX) syndrome. Front Immunol. 2018;9:2411.","journal-title":"Front Immunol"},{"issue":"7","key":"1791_CR2","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1007\/s10875-022-01352-z","volume":"42","author":"A Bousfiha","year":"2022","unstructured":"Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42(7):1508\u201320.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1791_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jaip.2022.10.003","volume":"11","author":"S Baris","year":"2023","unstructured":"Baris S, Abolhassani H, Massaad MJ, Al-Nesf M, Chavoshzadeh Z, Keles S, et al. The Middle East and North Africa Diagnosis and management guidelines for inborn errors of immunity. J Allergy Clin Immunol Pract. 2023;11(1):158-80.e11.","journal-title":"J Allergy Clin Immunol Pract."},{"key":"1791_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fped.2019.00020","volume":"7","author":"C Agakidis","year":"2019","unstructured":"Agakidis C, Agakidou E, Sarafidis K, Papoulidis I, Xinias I, Farmaki E. Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome associated with a novel mutation of FOXP3 gene. Front Pediatr. 2019;7:20.","journal-title":"Front Pediatr"},{"key":"1791_CR5","doi-asserted-by":"publisher","first-page":"612760","DOI":"10.3389\/fped.2021.612760","volume":"9","author":"F Barzaghi","year":"2021","unstructured":"Barzaghi F, Passerini L. IPEX syndrome: improved knowledge of immune pathogenesis empowers diagnosis. Front Pediatr. 2021;9:612760.","journal-title":"Front Pediatr"},{"key":"1791_CR6","doi-asserted-by":"publisher","first-page":"972746","DOI":"10.3389\/fimmu.2022.972746","volume":"13","author":"Y Huang","year":"2022","unstructured":"Huang Y, Fang S, Zeng T, Chen J, Yang L, Sun G, et al. Clinical and immunological characteristics of five patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in China-expanding the atypical phenotypes. Front Immunol. 2022;13:972746.","journal-title":"Front Immunol"},{"key":"1791_CR7","doi-asserted-by":"publisher","unstructured":"Bacchetta R, Roncarolo MG. IPEX Syndrome from diagnosis to cure, learning along the way. J Allergy Clin Immunol. 2023. https:\/\/doi.org\/10.1016\/j.jaci.2023.11.021","DOI":"10.1016\/j.jaci.2023.11.021"},{"issue":"1","key":"1791_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.13011","volume":"1417","author":"R Bacchetta","year":"2018","unstructured":"Bacchetta R, Barzaghi F, Roncarolo MG. From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation. Ann N Y Acad Sci. 2018;1417(1):5\u201322.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1791_CR9","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jaci.2017.10.041","volume":"141","author":"F Barzaghi","year":"2018","unstructured":"Barzaghi F, Amaya Hernandez LC, Neven B, Ricci S, Kucuk ZY, Bleesing JJ, et al. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study. J Allergy Clin Immunol. 2018;141(3):1036-49.e5.","journal-title":"J Allergy Clin Immunol."},{"issue":"5","key":"1791_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S0022-3476(82)80573-8","volume":"100","author":"BR Powell","year":"1982","unstructured":"Powell BR, Buist NR, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr. 1982;100(5):731\u20137.","journal-title":"J Pediatr"},{"issue":"12","key":"1791_CR11","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1172\/JCI11679","volume":"106","author":"TA Chatila","year":"2000","unstructured":"Chatila TA, Blaeser F, Ho N, Lederman HM, Voulgaropoulos C, Helms C, et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest. 2000;106(12):R75-81.","journal-title":"J Clin Invest"},{"issue":"1","key":"1791_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","volume":"27","author":"CL Bennett","year":"2001","unstructured":"Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001;27(1):20\u20131.","journal-title":"Nat Genet"},{"key":"1791_CR13","doi-asserted-by":"publisher","first-page":"643094","DOI":"10.3389\/fped.2021.643094","volume":"9","author":"F Consonni","year":"2021","unstructured":"Consonni F, CiulliniMannurita S, Gambineri E. Atypical Presentations of IPEX: Expect the Unexpected. Front Pediatr. 2021;9:643094.","journal-title":"Front Pediatr"},{"issue":"1","key":"1791_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jaci.2022.09.013","volume":"151","author":"M Narula","year":"2023","unstructured":"Narula M, Lakshmanan U, Borna S, Schulze JJ, Holmes TH, Harre N, et al. Epigenetic and immunological indicators of IPEX disease in subjects with FOXP3 gene mutation. J Allergy Clin Immunol. 2023;151(1):233-46.e10.","journal-title":"J Allergy Clin Immunol."},{"key":"1791_CR15","doi-asserted-by":"publisher","first-page":"102461","DOI":"10.1016\/j.jaut.2020.102461","volume":"111","author":"X Zhang","year":"2020","unstructured":"Zhang X, Olsen N, Zheng SG. The progress and prospect of regulatory T cells in autoimmune diseases. J Autoimmun. 2020;111:102461.","journal-title":"J Autoimmun"},{"issue":"4","key":"1791_CR16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/ni1445","volume":"8","author":"W Lin","year":"2007","unstructured":"Lin W, Haribhai D, Relland LM, Truong N, Carlson MR, Williams CB, et al. Regulatory T cell development in the absence of functional Foxp3. Nat Immunol. 2007;8(4):359\u201368.","journal-title":"Nat Immunol"},{"issue":"5","key":"1791_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"6","key":"1791_CR18","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.jaci.2023.08.004","volume":"152","author":"N Taghizade","year":"2023","unstructured":"Taghizade N, Babayeva R, Kara A, Karakus IS, Catak MC, Bulutoglu A, et al. Therapeutic modalities and clinical outcomes in a large cohort with LRBA deficiency and CTLA4 insufficiency. J Allergy Clin Immunol. 2023;152(6):1634\u201345.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1791_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jaci.2023.01.023","volume":"152","author":"S Baris","year":"2023","unstructured":"Baris S, Benamar M, Chen Q, Catak MC, Martinez-Blanco M, Wang M, et al. Severe allergic dysregulation due to a gain of function mutation in the transcription factor STAT6. J Allergy Clin Immunol. 2023;152(1):182-94.e7.","journal-title":"J Allergy Clin Immunol."},{"issue":"10","key":"1791_CR20","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1111\/all.15331","volume":"77","author":"MC Catak","year":"2022","unstructured":"Catak MC, Akcam B, BilgicEltan S, Babayeva R, Karakus IS, Akgun G, et al. Comparing the levels of CTLA-4-dependent biological defects in patients with LRBA deficiency and CTLA-4 insufficiency. Allergy. 2022;77(10):3108\u201323.","journal-title":"Allergy"},{"issue":"4","key":"1791_CR21","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s10875-020-00943-y","volume":"41","author":"B Kayaoglu","year":"2021","unstructured":"Kayaoglu B, Kasap N, Yilmaz NS, Charbonnier LM, Geckin B, Akcay A, et al. Stepwise reversal of immune dysregulation due to STAT1 gain-of-function mutation following ruxolitinib bridge therapy and transplantation. J Clin Immunol. 2021;41(4):769\u201379.","journal-title":"J Clin Immunol"},{"issue":"8","key":"1791_CR22","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1016\/j.jaip.2019.06.011","volume":"7","author":"A Kiykim","year":"2019","unstructured":"Kiykim A, Ogulur I, Dursun E, Charbonnier LM, Nain E, Cekic S, et al. Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency. J Allergy Clin Immunol Pract. 2019;7(8):2790-800.e15.","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"3","key":"1791_CR23","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/all.15010","volume":"77","author":"B Kolukisa","year":"2022","unstructured":"Kolukisa B, Baser D, Akcam B, Danielson J, BilgicEltan S, Haliloglu Y, et al. Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency. Allergy. 2022;77(3):1004\u201319.","journal-title":"Allergy"},{"issue":"3","key":"1791_CR24","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s10875-021-01191-4","volume":"42","author":"AP Sefer","year":"2022","unstructured":"Sefer AP, Abolhassani H, Ober F, Kayaoglu B, BilgicEltan S, Kara A, et al. Expanding the clinical and immunological phenotypes and natural history of MALT1 deficiency. J Clin Immunol. 2022;42(3):634\u201352.","journal-title":"J Clin Immunol"},{"issue":"D1","key":"1791_CR25","doi-asserted-by":"publisher","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","volume":"50","author":"M Varadi","year":"2022","unstructured":"Varadi M, Anyango S, Deshpande M, Nair S, Natassia C, Yordanova G, et al. AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 2022;50(D1):D439\u201344.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1791_CR26","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1093\/bioinformatics\/bts005","volume":"28","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Wang L, Gao Y, Zhang J, Zhenirovskyy M, Alexov E. Predicting folding free energy changes upon single point mutations. Bioinformatics. 2012;28(5):664\u201371.","journal-title":"Bioinformatics"},{"issue":"12","key":"1791_CR27","doi-asserted-by":"publisher","first-page":"e1008543","DOI":"10.1371\/journal.pcbi.1008543","volume":"16","author":"Y Chen","year":"2020","unstructured":"Chen Y, Lu H, Zhang N, Zhu Z, Wang S, Li M. PremPS: Predicting the impact of missense mutations on protein stability. PLoS Comput Biol. 2020;16(12):e1008543.","journal-title":"PLoS Comput Biol"},{"key":"1791_CR28","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s10875-014-0059-7","volume":"34","author":"S Baris","year":"2014","unstructured":"Baris S, Schulze I, Ozen A, Aydiner EK, Altuncu E, Karasu GT, et al. Clinical heterogeneity of immunodysregulation, polyendocrinopathy, enteropathy, X-linked: pulmonary involvement as a non-classical disease manifestation. J Clin Immunol. 2014;34:601\u20136.","journal-title":"J Clin Immunol"},{"issue":"9","key":"1791_CR29","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41590-019-0442-x","volume":"20","author":"LM Charbonnier","year":"2019","unstructured":"Charbonnier LM, Cui Y, Stephen-Victor E, Harb H, Lopez D, Bleesing JJ, et al. Functional reprogramming of regulatory T cells in the absence of Foxp3. Nat Immunol. 2019;20(9):1208\u201319.","journal-title":"Nat Immunol"},{"issue":"8","key":"1791_CR30","doi-asserted-by":"publisher","first-page":"113018","DOI":"10.1016\/j.celrep.2023.113018","volume":"42","author":"J Leon","year":"2023","unstructured":"Leon J, Chowdhary K, Zhang W, Ramirez RN, Andre I, Hur S, et al. Mutations from patients with IPEX ported to mice reveal different patterns of FoxP3 and Treg dysfunction. Cell Rep. 2023;42(8):113018.","journal-title":"Cell Rep"},{"issue":"5","key":"1791_CR31","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41590-021-00910-8","volume":"22","author":"D Zemmour","year":"2021","unstructured":"Zemmour D, Charbonnier LM, Leon J, Six E, Keles S, Delville M, et al. Single-cell analysis of FOXP3 deficiencies in humans and mice unmasks intrinsic and extrinsic CD4(+) T cell perturbations. Nat Immunol. 2021;22(5):607\u201319.","journal-title":"Nat Immunol"},{"key":"1791_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fped.2017.00267","volume":"5","author":"T Ge","year":"2017","unstructured":"Ge T, Wang Y, Che Y, Xiao Y, Zhang T. Atypical late-onset immune dysregulation, polyendocrinopathy, enteropathy, X-Linked syndrome with intractable diarrhea: a case report. Front Pediatr. 2017;5:267.","journal-title":"Front Pediatr"},{"issue":"6","key":"1791_CR33","first-page":"e221","volume":"30","author":"A Martin-Santiago","year":"2013","unstructured":"Martin-Santiago A, Hervas JA, Hervas D, Rosell A, Caimari M, de Carlos JC, et al. Diagnostic value of the skin lesions in immune dysregulation, polyendocrinopathy, enteropathy. X-linked syndrome Pediatr Dermatol. 2013;30(6):e221\u20132.","journal-title":"X-linked syndrome Pediatr Dermatol"},{"key":"1791_CR34","doi-asserted-by":"crossref","unstructured":"Patey-Mariaud de Serre N, Canioni D, Ganousse S, Rieux-Laucat F, Goulet O, Ruemmele F, et al. Digestive histopathological presentation of IPEX syndrome. Mod Pathol. 2009;22(1):95\u2013102.","DOI":"10.1038\/modpathol.2008.161"},{"issue":"7","key":"1791_CR35","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00467-015-3102-x","volume":"30","author":"Y Sheikine","year":"2015","unstructured":"Sheikine Y, Woda CB, Lee PY, Chatila TA, Keles S, Charbonnier LM, et al. Renal involvement in the immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) disorder. Pediatr Nephrol. 2015;30(7):1197\u2013202.","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"1791_CR36","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.jaci.2010.09.001","volume":"126","author":"AN McMurchy","year":"2010","unstructured":"McMurchy AN, Gillies J, Allan SE, Passerini L, Gambineri E, Roncarolo MG, et al. Point mutants of forkhead box P3 that cause immune dysregulation, polyendocrinopathy, enteropathy, X-linked have diverse abilities to reprogram T cells into regulatory T cells. J Allergy Clin Immunol. 2010;126(6):1242\u201351.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1791_CR37","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/pedi.12612","volume":"19","author":"JL Hwang","year":"2018","unstructured":"Hwang JL, Park SY, Ye H, Sanyoura M, Pastore AN, Carmody D, et al. FOXP3 mutations causing early-onset insulin-requiring diabetes but without other features of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Pediatr Diabetes. 2018;19(3):388\u201392.","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"1791_CR38","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jaci.2008.09.027","volume":"122","author":"E Gambineri","year":"2008","unstructured":"Gambineri E, Perroni L, Passerini L, Bianchi L, Doglioni C, Meschi F, et al. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity. J Allergy Clin Immunol. 2008;122(6):1105-12.e1.","journal-title":"J Allergy Clin Immunol."},{"issue":"3","key":"1791_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1177\/1093526621998868","volume":"24","author":"DT Duztas","year":"2021","unstructured":"Duztas DT, Al-Shadfan L, Ozturk H, Yazan H, Cakir E, Ekinci NUO, et al. New findings of immunodysregulation, polyendocrinopathy, and enteropathy X-linked syndrome (IPEX); granulomas in lung and duodenum. Pediatr Dev Pathol. 2021;24(3):252\u20137.","journal-title":"Pediatr Dev Pathol"},{"issue":"6","key":"1791_CR40","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/MOP.0000000000000029","volume":"25","author":"JW Verbsky","year":"2013","unstructured":"Verbsky JW, Chatila TA. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases. Curr Opin Pediatr. 2013;25(6):708\u201314.","journal-title":"Curr Opin Pediatr"},{"issue":"1","key":"1791_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s10875-015-0218-5","volume":"36","author":"MG Seidel","year":"2016","unstructured":"Seidel MG, Boztug K, Haas OA. Immune dysregulation syndromes (IPEX, CD27 Deficiency, and Others): always doomed from the start? J Clin Immunol. 2016;36(1):6\u20137.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1791_CR42","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/MPG.0b013e3181a159de","volume":"49","author":"M Scaillon","year":"2009","unstructured":"Scaillon M, Van Biervliet S, Bontems P, Dorchy H, Hanssens L, Ferster A, et al. Severe gastritis in an insulin-dependent child with an IPEX syndrome. J Pediatr Gastroenterol Nutr. 2009;49(3):368\u201370.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1791_CR43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13052-014-0068-4","volume":"40","author":"D Zama","year":"2014","unstructured":"Zama D, Cocchi I, Masetti R, Specchia F, Alvisi P, Gambineri E, et al. Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea. Ital J Pediatr. 2014;40:68.","journal-title":"Ital J Pediatr"},{"issue":"4","key":"1791_CR44","doi-asserted-by":"publisher","first-page":"580","DOI":"10.24953\/turkjped.2019.04.015","volume":"61","author":"D Dogruel","year":"2019","unstructured":"Dogruel D, Gurbuz F, Turan I, Altintas DU, Yilmaz M, Yuksel B. Unusual and early onset IPEX syndrome: a case report. Turk J Pediatr. 2019;61(4):580\u20134.","journal-title":"Turk J Pediatr"},{"issue":"10","key":"1791_CR45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41424-018-0064-x","volume":"9","author":"R Duclaux-Loras","year":"2018","unstructured":"Duclaux-Loras R, Charbit-Henrion F, Neven B, Nowak J, Collardeau-Frachon S, Malcus C, et al. Clinical heterogeneity of immune dysregulation, polyendocrinopathy, enteropathy, X-Linked syndrome: a French multicenter retrospective study. Clin Transl Gastroenterol. 2018;9(10):201.","journal-title":"Clin Transl Gastroenterol"},{"issue":"6","key":"1791_CR46","doi-asserted-by":"publisher","first-page":"102526","DOI":"10.1016\/j.autrev.2020.102526","volume":"19","author":"JH Park","year":"2020","unstructured":"Park JH, Lee KH, Jeon B, Ochs HD, Lee JS, Gee HY, et al. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: a systematic review. Autoimmun Rev. 2020;19(6):102526.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"1791_CR47","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/s10875-022-01262-0","volume":"42","author":"E Ozturk","year":"2022","unstructured":"Ozturk E, Catak MC, Kiykim A, Baser D, BilgicEltan S, Yalcin K, et al. Clinical and laboratory factors affecting the prognosis of severe combined immunodeficiency. J Clin Immunol. 2022;42(5):1036\u201350.","journal-title":"J Clin Immunol"},{"issue":"5","key":"1791_CR48","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/eji.202149210","volume":"52","author":"S Borna","year":"2022","unstructured":"Borna S, Lee E, Sato Y, Bacchetta R. Towards gene therapy for IPEX syndrome. Eur J Immunol. 2022;52(5):705\u201316.","journal-title":"Eur J Immunol"},{"issue":"9","key":"1791_CR49","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2012-09-457465","volume":"121","author":"T Kinnunen","year":"2013","unstructured":"Kinnunen T, Chamberlain N, Morbach H, Choi J, Kim S, Craft J, et al. Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells. Blood. 2013;121(9):1595\u2013603.","journal-title":"Blood"},{"issue":"6","key":"1791_CR50","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1172\/JCI25112","volume":"116","author":"R Bacchetta","year":"2006","unstructured":"Bacchetta R, Passerini L, Gambineri E, Dai M, Allan SE, Perroni L, et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations. J Clin Invest. 2006;116(6):1713\u201322.","journal-title":"J Clin Invest"},{"issue":"6","key":"1791_CR51","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s002510100358","volume":"53","author":"CL Bennett","year":"2001","unstructured":"Bennett CL, Brunkow ME, Ramsdell F, O\u2019Briant KC, Zhu Q, Fuleihan RL, et al. A rare polyadenylation signal mutation of the FOXP3 gene (AAUAAA\u2013>AAUGAA) leads to the IPEX syndrome. Immunogenetics. 2001;53(6):435\u20139.","journal-title":"Immunogenetics"},{"issue":"2","key":"1791_CR52","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.immuni.2018.12.016","volume":"50","author":"F Van Gool","year":"2019","unstructured":"Van Gool F, Nguyen MLT, Mumbach MR, Satpathy AT, Rosenthal WL, Giacometti S, et al. A mutation in the transcription factor Foxp3 drives T helper 2 effector function in regulatory T cells. Immunity. 2019;50(2):362-77.e6.","journal-title":"Immunity."},{"issue":"2","key":"1791_CR53","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.immuni.2017.07.008","volume":"47","author":"N Hayatsu","year":"2017","unstructured":"Hayatsu N, Miyao T, Tachibana M, Murakami R, Kimura A, Kato T, et al. Analyses of a mutant Foxp3 allele reveal BATF as a critical transcription factor in the differentiation and accumulation of tissue regulatory T cells. Immunity. 2017;47(2):268-83.e9.","journal-title":"Immunity."},{"issue":"727","key":"1791_CR54","doi-asserted-by":"publisher","first-page":"eadg6822","DOI":"10.1126\/scitranslmed.adg6822","volume":"15","author":"S Borna","year":"2023","unstructured":"Borna S, Lee E, Nideffer J, Ramachandran A, Wang B, Baker J, et al. Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with FOXP3 mutations. Sci Transl Med. 2023;15(727):eadg6822.","journal-title":"Sci Transl Med."},{"key":"1791_CR55","doi-asserted-by":"publisher","first-page":"102298","DOI":"10.1016\/j.coi.2023.102298","volume":"81","author":"CS Ma","year":"2023","unstructured":"Ma CS. T-helper-2 cells and atopic disease: lessons learnt from inborn errors of immunity. Curr Opin Immunol. 2023;81:102298.","journal-title":"Curr Opin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01791-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-024-01791-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01791-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:02:29Z","timestamp":1777309349000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-024-01791-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1791"],"URL":"https:\/\/doi.org\/10.1007\/s10875-024-01791-w","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"8 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Marmara University, School of Medicine (09.2018.624).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent for participation was obtained from all individuals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Informed publication consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"9"}}